For patients in hospital or surgery, real-time blood chemistry monitoring and glycemic control are critical. Correcting abnormal glucose levels and keeping them normal speeds recovery, prevents infection, and reduces complications. Early detection of sepsis is crucial to increase the chances of survival. To date, this has been difficult, highly labor-intensive, and imprecise. That is about to change.
Admetsys has developed a first-of-its-kind real-time diagnostic platform and closed-loop artificial pancreas for hospital and surgical care, leveraging adaptive learning algorithms and counterbalancing treatment of insulin and glucose.
between 80-125 mg/dL
< 70 mg/dL
In one retrospective study, average
frequency was 2.6 hours despite
a goal of hourly checks.
A 12-minute measurement delay (from hourly)
was associated with 67% of severe
86% of nurses in one study felt that an easier or more automated
form of measurement was needed.
33% Increase over 5 years
(2012 to 2017)
30% of the total medical cost
– hospital inpatient care
160% Increase over 6 years
(2013 to 2019)